AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

171.570

-0.750-0.44%

Volume:1.67M

Turnover:287.13M

Market Cap:82.17B

PE:-22.98

High:173.690

Open:171.500

Low:170.750

Close:172.320

52wk High:219.589

52wk Low:90.000

Shares:478.91M

Float Shares:478.91M

Volume Ratio:1.55

T/O Rate:0.35%

Dividend:4.12

Dividend Rate:2.40%

EPS(TTM):-7.466

EPS(LYR):-7.466

ROE:-15.83%

ROA:7.26%

PB:3.98

PE(LYR):-22.98

Loading ...

Overview Company News Filings

Haemonetics Signs Non-Exclusive US Plasma Supply Deal with CSL Plasma for NexSys PCS Devices, Disposables

CSL (ASX:CSL) Shares Confront Profit Reversal As Recovery Case Stays Unproven

Simply Wall St.

Switzerland's Basilea H1 Revenue Rises on Cresemba Demand; Ups 2026 Profit Outlook

CSL Expects Flat Revenue for Fiscal 2027 With Return to Profit Growth

MT Newswires Live

CSL's Fiscal 2026 Results In Line, Jefferies Says

MT Newswires Live

Australia's CSL Eyes Best Day in 25 Years on Strong FY Outlook

Csl FY Adjusted Net Income USD 3,100 Million

Shares of CSL Limited up 12.9% at A$152 in Early Trade After Annual Results

THOMSON REUTERS

Australia's CSL Surges 18% on Earnings Beat, Upbeat Plasma Business Forecast

CSL Fiscal 2026 Underlying NPATA Earnings Per Share Down, Revenue Up

MT Newswires Live

CSL FY26 Underlying NPATA Falls 2% to Us$3.1 Billion; Reported Net Loss Widens to Us$2.6 Billion

CSL Final Dividend Us$1.62 Per Share

THOMSON REUTERS

CSL Limited - Announce a Further A$1.1 Billion Share Buy-Back Program

THOMSON REUTERS

CSL Limited - Recognised Pre-Tax Impairments of $5.5 Billion in 2H FY26

THOMSON REUTERS

CSL Limited Sees FY Underlying Npat Growth of Approximately 5%

THOMSON REUTERS

CSL Limited - Intention to Spend Approximately $1.5 Billion to Expand Its U.S. Plasma Manufacturing Presence

THOMSON REUTERS

CSL FY Adjusted Net Income USD 3,100 Million

THOMSON REUTERS

CSL Limited - CSL Seqirus Expects Low Single Digit Revenue Growth in FY

THOMSON REUTERS

3 ASX Dividend Stocks Paying Investors While They Wait

Simply Wall St.

Accenture Stock And 2 More Dividend Shares Yielding Over 3%

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/CSL.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":171.57,"timestamp":1788156720000,"preClose":172.32,"halted":0,"volume":1673346,"delay":0,"changeRate":-0.004352367688022284,"nameEN":"CSL LIMITED","floatShares":478911979,"shares":478911979,"eps":-7.465956633258256,"marketStatus":"Not Yet Opened","change":-0.75,"latestTime":"08-31 16:12:00 AEST","open":171.5,"high":173.69,"low":170.75,"amount":287126143,"amplitude":0.017061,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.465956633258256,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":172.32,"dividendRate":0.024,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":1.5502278355605044,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":171.57,"auctionPrice":171,"auctionVolume":4968,"auctionTime":1788217565959,"referenceTime":1788172203092,"auction":1,"marketStatus":"盘前竞价","timestamp":1788217565959}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":478911979,"roa":"7.26%","roe":"-15.83%","lyrEps":-7.465957,"volumeRatio":1.5502278355605044,"shares":478911979,"dividePrice":4.1177,"high":173.69,"amplitude":0.017061,"preClose":172.32,"low":170.75,"week52Low":90,"pbRate":"3.98","psRate":"3.73","week52High":219.589,"institutionHeld":0,"latestPrice":171.57,"eps":-7.465956633258256,"divideRate":0.024,"volume":1673346,"delay":0,"ttmEps":-7.465956633258256,"open":171.5,"prevYearClose":170.408,"prevWeekClose":172.32,"prevMonthClose":171.57,"prevQuarterClose":114.74,"fiveDayClose":169.11,"twentyDayClose":124.3,"sixtyDayClose":97.91,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":5,"dividendGrowthRate":0.003543182641490467,"fiveYearAvgDividendRate":0.018567360626050477},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-10","defaultRemindTime":1788912000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-02","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1788876000000,"payDate":"2026-10-02"},{"date":"2026-08-18","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660466734","title":"Haemonetics Signs Non-Exclusive US Plasma Supply Deal with CSL Plasma for NexSys PCS Devices, Disposables","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466734?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:06","pubTimestamp":1787047565,"startTime":"0","endTime":"0","summary":"Haemonetics signs non-exclusive US plasma supply deal with CSL Plasma for NexSys PCS devices, disposablesHaemonetics signed a non-exclusive U.S. supply agreement with CSL Plasma on Aug. 14, 2026 for N","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLpVv5B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","CSL.AU","BK7501","LU1169589451.USD","IE00B64QTZ34.USD","IE00BLDYK493.USD","BK7508","LU0205194284.USD","HAE","IE0034390439.USD","IE00B19Z6F94.USD","LU0106261612.USD","LU0205193047.USD","LU1169590202.USD","BK7511","LU0012050646.USD","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660466219","title":"CSL (ASX:CSL) Shares Confront Profit Reversal As Recovery Case Stays Unproven","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466219","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466219?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:22","pubTimestamp":1787044958,"startTime":"0","endTime":"0","summary":"CSL stock went into this result having climbed over the past quarter, closing at A$157.82, yet the latest numbers land with a jolt. The global biotech giant posted a trailing twelve month loss from continuing operations of US$2.99b on revenue of US$15.80b. That kind of earnings squeeze grabs short term traders by the throat. For long term investors, the real question now is how to weigh that loss against analyst forecasts that point to a return to profitability, as well as the current gap...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-shares-confront-profit-reversal-as-recovery-case","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-shares-confront-profit-reversal-as-recovery-case","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","FEBU","JOYT","GXDW","VGFPF","BK7511","PMDE","SG9999004303.SGD","CSL.AU","LU0728928796.USD","BK4086","LU1169590202.USD","RGLO","SGXZ23171101.USD","BK7501","BK7508","CSL","LU1169589451.USD","VOTE","DECU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660454593","title":"Switzerland's Basilea H1 Revenue Rises on Cresemba Demand; Ups 2026 Profit Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2660454593","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660454593?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:26","pubTimestamp":1787030795,"startTime":"0","endTime":"0","summary":"Switzerland's Basilea H1 revenue rises on Cresemba demand; ups 2026 profit outlookOverviewSwitzerland biopharma firm's H1 2026 revenue grew 14% yr/yr to CHF 119 mlnOperating profit for H1 2026 rose 32","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL1N44F03R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","002422","BK1161","BK0060","LU1064131003.USD","BK7508","LU2148510915.USD","00656","02696","HK0000165453.HKD","HK0000320223.HKD","LU1979443071.USD","BK0239","BK7511","06990","HK0000306685.HKD","BK7067","BK7501","LU1934453819.USD","CSL.AU","LU0196878994.USD","BK1230","HK0000306701.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660645155","title":"CSL Expects Flat Revenue for Fiscal 2027 With Return to Profit Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2660645155","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660645155?lang=en_us&edition=fundamental","pubTime":"2026-08-18 12:24","pubTimestamp":1787027041,"startTime":"0","endTime":"0","summary":"CSL  expects fiscal 2027 revenue to be flat while making a return to profit growth after fiscal 2026 results beat estimates amid restructuring.The biotechnology company reported $6.43 in underlying NPATA earnings per share for fiscal 2026, compared with $6.65 a year ago and beating analysts' estimates surveyed by FactSet of $6.27.Revenue for the year was $15.8 billion, beating the estimate of $15.38 billion from analysts polled by FactSet, while paying restructuring costs of $799 million.The biotechnology firm attributed the results to \"strong fundamentals\" of the plasma industry and said momentum is building behind its newer therapy products.Looking ahead, CSL expects fiscal 2027 revenue to be flat with 5% growth in its underlying net profit after tax.\"CSL is positioned for a return to sustainable growth, supported by solid plasma market fundamentals, a simplified business and targeted investment in our commercial capabilities and development programs,\" said Interim Chief Executive Of","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660745574","title":"CSL's Fiscal 2026 Results In Line, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660745574","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660745574?lang=en_us&edition=fundamental","pubTime":"2026-08-18 10:00","pubTimestamp":1787018443,"startTime":"0","endTime":"0","summary":"CSL's  fiscal 2026 results are in line, and it guided for fiscal 2027 net profit after tax  growth of around 5%, Jefferies said in a Tuesday note.The firm's normalized fiscal 2026 net profit after tax and before amortization of $3.1 billion fell around 4% year-over-year and 2% in constant currency, compared with the brokerage's forecast of $3.09 billion.Its fiscal 2026 normalized earnings per share of $5.38 decreased around 3% on the year-ago period, compared with Jefferies' estimate of $5.76.Its fiscal 2027 revenue is expected by the firm to be in line with the prior year and underlying NPAT growth of around 5%, implying an underlying CSL fiscal 2027 NPAT of around $2.98 billion on a constant currency basis, compared with Jefferies' forecast of $2.8 billion on a non-constant currency basis.The investment firm assigned CSL a hold rating and a price target of AU$119 per share.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL.AU","BK4086","BK7067","LU1169590202.USD","SG9999004303.SGD","BK7501","LU0728928796.USD","LU1169589451.USD","SGXZ23171101.USD","BK7508","CSL","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453002","title":"Australia's CSL Eyes Best Day in 25 Years on Strong FY Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453002","media":"Reuters","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660453002?lang=en_us&edition=fundamental","pubTime":"2026-08-18 09:20","pubTimestamp":1787016055,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's CSL eyes best day in 25 years on strong FY outlook** Shares of CSLCSL.AXrise as much as 18.1% to A$159.01, hitting their highest level since February 12** Stock set for best intraday trading session since June 2001** Biotech giant reportsbetter-than-expectedfull-year underlying earnings and forecasts strong growth in 2027 on the back of its core plasma division** CSL posts underlying NPAT attributable of $3.14 bln on a constant currency basis, topping Visible Alpha consensus estimate of $3.08 bln** Plasma therapies unit CSL Behring expected to post mid-single-digit revenue growth in FY 2027** Co unveils A$1.1 bln  share buyback programme** With much of the earnings damage already reflected in a share price near multi-year lows, the buyback and a more constructive outlook for Behring are strengthening view that the worst may be behind CSL - Hebe Chen, market analyst at Vantage Markets** Day's moves cut stock's YTD losses to 9.2%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL4N44F01G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","LU2089283258.USD","BK4566","LU2095319765.USD","FDIQ","LU0097036916.USD","SG9999017495.SGD","LU2089284900.SGD","LU1989764664.SGD","LU1989773731.SGD","LU2506952170.USD","LU2506952097.USD","BK7501","LU0342679015.USD","LU1989763005.USD","SG9999001077.SGD","LU1804176565.USD","LU1989772923.USD","LU2764263039.SGD","LU1496350502.SGD","BK4534","BK4548","BK7067","SPGI","LU2506951875.HKD","LU0868494617.USD","LU2720916845.USD","SG9999014898.SGD","LU0345774631.USD","BK4585","LU0158827948.USD","BK4597","LU0094547139.USD","LU0175139822.USD","LU2210150020.SGD","LU0154236417.USD","BK4581","IE00B19Z9505.USD","LU2265009873.SGD","IAI","LU1633808545.USD","LU0823417737.USD","SGXZ31699556.SGD","LU1988902786.USD","LU0158827781.USD","LU1363072403.SGD","LU0354030438.USD","LU2271345857.HKD","BK4112","SG9999014880.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453908","title":"Csl FY Adjusted Net Income USD 3,100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453908","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660453908?lang=en_us&edition=fundamental","pubTime":"2026-08-18 09:02","pubTimestamp":1787014965,"startTime":"0","endTime":"0","summary":"BRIEF-Csl FY Adjusted Net Income USD 3,100 MillionAug 18 -CSL LimitedCSL.AX:FY ADJUSTED NET INCOME USD 3,100 MILLIONSEES FY UNDERLYING NPAT GROWTH OF  APPROXIMATELY 5%DIVIDEND MAINTAINED; SHARE BUY-BACK  PROGRAM CONTINUEDCSL SEQIRUS EXPECTS LOW SINGLE DIGIT REVENUE GROWTH IN FYSEES FY27 REVENUE TO BE IN LINE WITH THE PRIOR YEAR AND UNDERLYING NPAT GROWTH OF APPROXIMATELY 5%CSL BEHRING EXPECTS MID-SINGLE DIGIT REVENUE GROWTH IN FYANNOUNCE A FURTHER  A$1.1 BILLION SHARE BUY-BACK PROGRAMRECOGNISED PRE-TAX IMPAIRMENTS OF $5.5 BILLION IN 2H FY26INTENTION TO SPEND APPROXIMATELY $1.5 BILLION TO EXPAND ITS U.S. PLASMA  MANUFACTURING PRESENCEFurther company coverage:CSL.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nPLXMQ2BQ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7501","BK7067","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660458382","title":"Shares of CSL Limited up 12.9% at A$152 in Early Trade After Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660458382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660458382?lang=en_us&edition=fundamental","pubTime":"2026-08-18 08:02","pubTimestamp":1787011343,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44E0WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","CSL.AU","BK7067","BK7511","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660305504","title":"Australia's CSL Surges 18% on Earnings Beat, Upbeat Plasma Business Forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2660305504","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660305504?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:54","pubTimestamp":1787007265,"startTime":"0","endTime":"0","summary":"UPDATE 2-Australia's CSL surges 18% on earnings beat, upbeat plasma business forecastAug 18 (Reuters)-CSLCSL.AXreported better-than-expected annual underlying earnings on Tuesday and forecast growth i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4N44E1FT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2506952097.USD","LU0950375773.USD","SG9999014914.USD","BK4585","SG9999001077.SGD","LU0175139822.USD","SGXZ31699556.SGD","BK4548","SG9999014880.SGD","LU1989764664.SGD","LU1989773731.SGD","LU2506951875.HKD","LU0345774631.USD","LU0289960550.SGD","LU1496350171.SGD","IE00B19Z9505.USD","BK4112","LU2265009873.SGD","LU0094547139.USD","LU0868494617.USD","SG9999014898.SGD","LU2023251221.USD","LU0345774391.USD","BK4566","LU0823417653.USD","LU2506951958.HKD","LU2720916845.USD","LU2089283258.USD","LU2210150020.SGD","LU0823417737.USD","LU0971096721.USD","LU2264538146.SGD","BK7501","LU2764263203.CNY","LU1496350502.SGD","LU1064131342.USD","LU1804176565.USD","CSL.AU","LU0985320562.USD","IAI","SG9999017495.SGD","LU2506952170.USD","SG9999018857.SGD","LU2271345857.HKD","LU2089284900.SGD","SPGI","BK4581","FDIQ","LU0097036916.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660038437","title":"CSL Fiscal 2026 Underlying NPATA Earnings Per Share Down, Revenue Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2660038437","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660038437?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:27","pubTimestamp":1787005653,"startTime":"0","endTime":"0","summary":"CSL  logged $6.43 in underlying NPATA earnings per share for fiscal 2026, compared with $6.65 a year ago, a Tuesday filing showed.Analysts polled by FactSet expected $6.27.For the 12 months ended June 30, revenue was $15.8 billion versus $15.56 billion previously, the Australia-listed biotechnology company added. Analysts surveyed by FactSet expected $15.38 billion.The company's board declared a final dividend of $1.62 per share, unchanged from a year earlier, payable Oct. 2 to shareholders of record as of Sept. 10.CSL said it expects fiscal 2027 revenue to be in line with fiscal 2026, and underlying net profit after tax growth of about 5%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437278","title":"CSL FY26 Underlying NPATA Falls 2% to Us$3.1 Billion; Reported Net Loss Widens to Us$2.6 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437278","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437278?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:14","pubTimestamp":1787004898,"startTime":"0","endTime":"0","summary":"CSL FY26 underlying NPATA falls 2% to US$3.1 billion; reported net loss widens to US$2.6 billionCSL posted a net loss after tax of US$2.6 billion, swinging from profit, on one-off restructuring costs,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL2bJkFB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7511","BK7067","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660371724","title":"CSL Final Dividend Us$1.62 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2660371724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660371724?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004013,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLX31HNDN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","CSL.AU","BK7511","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437484","title":"CSL Limited - Announce a Further A$1.1 Billion Share Buy-Back Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437484","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437484?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","CSL.AU","BK7511","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437482","title":"CSL Limited - Recognised Pre-Tax Impairments of $5.5 Billion in 2H FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437482?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","BK7511","BK7501","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437178","title":"CSL Limited Sees FY Underlying Npat Growth of Approximately 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437178","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437178?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7501","CSL.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660374874","title":"CSL Limited - Intention to Spend Approximately $1.5 Billion to Expand Its U.S. Plasma Manufacturing Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2660374874","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660374874?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7067","BK7501","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660371084","title":"CSL FY Adjusted Net Income USD 3,100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660371084","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660371084?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7501","BK7508","BK7067","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660176437","title":"CSL Limited - CSL Seqirus Expects Low Single Digit Revenue Growth in FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2660176437","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660176437?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","BK7501","CSL.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431738","title":"3 ASX Dividend Stocks Paying Investors While They Wait","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431738","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431738?lang=en_us&edition=fundamental","pubTime":"2026-08-18 01:19","pubTimestamp":1786987170,"startTime":"0","endTime":"0","summary":"With central banks keeping policy paths in sharp focus and 10Y bond yields edging higher, income investors are being asked to work harder for dependable cash flow. That is where Dividend Powerhouses with 5%+ yields and solid coverage come into play, offering income potential while capital is deployed. These stocks are designed to pay you while you wait. This article walks through three standouts from the screener and explains what makes each one worth a closer look.\nThe three stocks below are...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-asx-dividend-stocks-paying-investors-while-they-wait","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-asx-dividend-stocks-paying-investors-while-they-wait","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CSL.AU","BK7501","GXDW","BK4585","VGFPF","BK4211","ISBC","PMDE","RGLO","BK7033","CBA.AU","QTOC","BK7508","VIG","SPHQ","BK7511","BK7067","DECU","BK7503","BK4588","CPU.AU","FEBU","VOTE","BK7157","BK7135","JOYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659017849","title":"Accenture Stock And 2 More Dividend Shares Yielding Over 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659017849","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659017849?lang=en_us&edition=fundamental","pubTime":"2026-08-15 16:22","pubTimestamp":1786782156,"startTime":"0","endTime":"0","summary":"Central banks in several countries are holding policy rates steady while inflation pressures remain uneven. That mix keeps bond yields and cash returns uncertain, which makes reliable income from equities more appealing. Dividend Powerhouses can offer regular cash payouts that do not depend on policy meetings every few months. This article walks through 3 stocks from the Dividend Powerhouses screener that currently offer 3%+ yields with a focus on coverage and stability.\nThe three stocks...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/accenture-stock-and-2-more-dividend-shares-yielding-over-3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/accenture-stock-and-2-more-dividend-shares-yielding-over-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0942090050.USD","IISV.AU","LU0323239441.USD","OZF.AU","LU0553294199.USD","LU1003077747.HKD","QFN.AU","XJO.AU","CBA.AU","VTHR","CSL.AU","IE000M9KFDE8.USD","LU2133065610.SGD","IMLC.AU","LU1585245621.USD","CHAT","LU1116320901.HKD","XKO.AU","QRE.AU","DACE.AU","LU0265550946.USD","BEAR.AU","SG9999014914.USD","LU1116320737.USD","LU0949170772.SGD","ARTY","ACN","VIG","IIGF.AU","BK4581","AIPO","GEAR.AU","QTOC","VAP.AU","EIGA.AU","OZR.AU","E200.AU","LU0545039389.USD","SLF.AU","SG9999014906.USD","IOZ.AU","LU0342679015.USD","GIVE.AU","ZYAU.AU","AGIX","BBOZ.AU","XAO.AU","VAS.AU","LU0738911758.USD","STW.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}